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MRI breastAbstract Objective: To demonstrate the role of ultrasound elastography and magnetic resonance
spectroscopy in diagnosis of solid breast lesions with histopathological correlation.
Patients and methods: This study included 40 female patients, and their ages ranged from 17 to
73 years with mean age of 43.18 years. Patients were referred on the basis of suspected breast lesion
and/or nipple discharge. All patients underwent elastography in addition to conventional ultra-
sonography and MR spectroscopy and the radiological results were correlated with histopatholog-
ical examination for achieving conﬁrmed ﬁnal diagnosis.
Results: All benign lesions were 17 on the basis of elastography, while the malignant lesions were
18. Fifteen malignant lesions (93.7%, 15/21) had an elastography score 5, while Thirteen benign
lesions (86.7%, 13/19) had an elastography score 3. On the basis of DCE-MRI, benign lesions were
16, while the malignant lesions were 19. Sixteen malignant lesions (94.1%) were diagnosed as
BI-RADS 5, while fourteen benign lesions (93.3%) were diagnosed as BI-RADS 3. On the basis
of MR spectroscopy, benign lesions were 17, while the malignant lesions were 19. Nineteen malig-
nant lesions (90.5) had positive choline peak while seventeen benign lesions (89.5%) had negative
choline peak. The study showed conventional ultrasound sensitivity, speciﬁcity, PPV, NPV and
accuracy as 85%, 80%, 80.9%, 84.2% and 82.5% respectively, and sono-elastography sensitivity,
speciﬁcity, PPV, NPV and accuracy as 90%, 85%, 85.7%, 89.4% and 87.5% respectively.
Dynamic contrast enhanced MRI sensitivity, speciﬁcity, PPV, NPV and accuracy were 85.7%,
84.2%, 85.7%, 84.2% and 85% respectively, while MR spectroscopy sensitivity, speciﬁcity, PPV,
NPV and accuracy were 90.4%, 89.4%, 90.4%, 89.5% and 80.5% respectively.
Conclusion: The study showed that sono-elastography and MR spectroscopy are valuable nonin-
vasive diagnostic imaging techniques in diagnosis of early breast malignancy than any other diag-
nostic tools, consequently help to avoid nondesirable invasive surgical biopsy of the breast lesions.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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In the past, ultrasound was only considered useful for the
diagnosis of cysts, meanwhile, diagnosis of breast cancer has
been widely improved since the development of high resolution
ultrasound equipments. It improves the differential diagnosis
of benign and malignant lesions, local preoperative staging
and guided interventional diagnosis (1). Ultrasound has long
been used to distinguish between cysts and solid masses.
However, solid masses are not always malignant; for example,
both ﬁbroadenomas and scirrhous carcinomas are solid and
stiff, but only the latter are malignant (2). Breast elastography
is a new sonographic imaging technique which provides
information on breast lesions in addition to conventional
ultrasonography (US) and mammography as it provides a
noninvasive evaluation of the stiffness of a lesion (3).
Elastography has integrated the diagnostic ability of palpation
into an ultrasound instrument with a compressive probe and
reﬂects the tissue stiffness (hardness) and elasticity in response
to pressure, even in lesions that are not palpable by hand (4).
Magnetic resonance imaging has shown promise in character-
izing breast lesions and evaluating local extent of disease (5).
Magnetic resonance spectroscopy shows excellent speciﬁcity
in the detection of breast lesions. Choline is generally unde-
tectable in normal breast tissue, and increased levels of choline
compounds in a tumor are thought to be an indicator of the
activity of that tumor, suggesting that it is malignant. This
eliminates the need for biopsy, reduces patient morbidity,
and saves unnecessary cost and time for both the patient and
the medical staff (6).
The aim of the work was to demonstrate the role of
ultrasound elastography and magnetic resonance spectroscopy
in diagnosis of solid breast lesions with histopathological
correlation.
2. Patients and methods
This prospective study was performed during the period from
September 2012 to January 2014 at Radiodiagnosis
Department, Al-Azhar University Hospital (New Damietta)
and included 40 female patients, and their ages ranged from
17 to 73 years with mean age of 43.18 years. The patients were
referred from General Surgery Department, Damietta
Oncology Center and also from outpatient clinics on the basis
of suspected breast lesion and/or nipple discharge. Inclusion
criteria were as follows: patients with solid breast lesions,
and exclusion criteria were as follows: 1. Patients with non-
solid breast lesions and 2. Neoadjuvant chemotherapy or
biopsy before MR examination. This study was approved by
the local Ethics Committee, informed consent was taken from
all patients, and then they were subjected to the following.
2.1. History taking and clinical examination
2.1.1. Radiological examinations
2.1.1.1. Sonoelastography examination of the breast. Using
Ultrasonix, SP, Canada with a convex probe 2–5 MHz and
linear probe 5–10 MHz.
The lesions were characterized using BI-RADS ultrasound
descriptors of mass margin (circumscribed, obscured,
microlobulated, ill-deﬁned/indistinct or spiculated), shape(oval, round, lobular or irregular), orientation (parallel or
not parallel to the skin), matrix echogenicity and homogeneity
(anechoic, hypoechoic or hyperechoic; homogeneous or
heterogeneous) and attenuation (indifferent, shadowing or
enhancement). Additionally, any associated ﬁndings (e.g.
architectural distortion) or axillary lymphadenopathy was
noted.
Elastographic diagnostic criteria were as follows: hardness
of tissue is displayed in color tone, with increasing hardness
presented in ascending order of red, yellow, green and blue.
The hardness is scored on a scale of 1–5. Score 1 is deﬁned
as an overall green tone, whereas score 2 consists of a mosaic
of green, blue and red and score 3 is presented by a blue center
and green periphery. Scores 1–3 represent benign ﬁndings.
Score 4 is deﬁned as an almost blue color consistent with a
hypoechoic region and score 5 as a deﬁnite blue color beyond
that of a hypoechoic region. Malignant ﬁndings are repre-
sented by score 4 and score 5.
2.1.1.2. Dynamic MRI and MRS of the breast. Using MRI
machine (Philips, Achieva 1.5 Tesla-XR-Netherlands 2010).
Technical considerations of dynamic MRI for the breast
scanning protocol:
1. Patient preparation and position
 The patients were instructed not to have any metallic
objects such as cardiac pace makers and ocular
implants.
 Patients were instructed to avoid motions.
 Patients were imaged in prone position with breasts h-
anging dependently within phased array breast coil.
 The ideal time for examination was 4–17 days from ﬁr-
st day of menstrual cycle ‘‘less dense stroma and lower
breast water content’’ and the average scan time was 30–
45 min.
2. MRI imaging protocol
A. Initial scout views in axial, coronal and sagittal planes of
both breasts to verify the precise position of the lesion.
B. T1-weighted pulse sequence:Nonfat saturated T1 WI was
obtained by turbo spin echo (TSE) with the following param-
eters: Repetition time (TR): 450 ms, Echo time (TE): 14 ms,
Number of signal averages (NSA): 1, slice thickness/interslice
gap: 3 mm/0.0, ﬁeld of view (FOV): 300–360 mm, ﬂip angle:
90, matrix was 307 · 512 and acquisition time: 1.43 min.
C. T2-weighted pulse sequence:Nonfat saturated T2 WI was
obtained by TSE with the following parameters: TR: 4 ms, TE:
120 ms, NSA: 1, slice thickness/interslice gap: 3 mm/0.0, FOV:
300–360 mm, ﬂip angle: 90, matrix was 307 · 512 and acqui-
sition time: 1.17 min.
D. Spectral attenuated inversion recovery (SPAIR) (Fat
Sat.): SPAIR was obtained with the following parameters:
TR: 13 ms, TE: 70 ms, inversion delay: 80 ms, NSA: 2, slice
thickness/interslice gap: 3 mm/0.0, FOV 300–360 mm, ﬂip
angle: 90, matrix was 307 · 512 and acquisition time:
2.32 min.
E. Dynamic study: This study was obtained using a T1
weighted sequence with fat suppression dynamic. The dynamic
imaging consisted of 6 individual dynamic series each lasting
for 1:25–1:27 min; one was obtained before and ﬁve after rapid
bolus intravenous injection of gadopentetate dimeglumine at a
Table 1 Dynamic breast MRI pulse sequence parameters.
Parameters Sequences
T1 WI T2 WI SPAIR Dynamic
(THRIVE)
Repetition
time (TR)
450 ms 4 ms 13 ms 8 ms
Echo time
(TE)
14 ms 120 ms 70 ms 2 ms
Field of view
(FOV)
320 · 320 320 · 320 320 · 320 320 · 320
Slice
thickness
3 mm 3 mm 3 mm 2 mm
Interslices
gap
0 mm 0 mm 0 mm 0 mm
Matrix 307 · 512 307 · 512 307 · 512 307 · 512
Flip angle 90 90 90 20–25
NSA 1 1 2 3
Acquisition
time
1.43 min 1.17 min 2.32 min 1.25 min/1
individual series
Table 2 Distribution of patients regarding lactation.
State of patient Count Percent (%)
Nonlactating cases 37 92.5
Lactating cases 3 7.5
Total 40 100
Table 3 Distribution of patients regarding menopausal state.
Count Percent (%)
Perimenopausal 6 15
Postmenopausal 21 52.5
Childbearing 13 32.5
Total 40 100
Table 4 Distribution of patients regarding hormonal replace-
ment therapy (HRT) intake.
Count Percent (%)
Without HRT 30 75
With HRT 10 25
Total 40 100
Table 5 Distribution of patients regarding complaint and
clinical signs.
Patient complaint Count Percent (%)
Painless breast lump 28 70
Painful breast lump 6 15
Nipple discharge 4 10
Palpable axillary lymph node 2 5
Total 40 100
Role of sonoelastography and MR spectroscopy 1303dose of 0.1 mmol per kilogram of body weight, followed by a
20 mL sterile saline solution ﬂush. After the dynamic series,
image subtraction was done to suppress the signal from fat.
The used MRI pulse sequence parameters are detailed in
Table 1 (see Tables 2–5).
F. MRS acquisition: A single-voxel 1H MRS was performed
using a point-resolved spectroscopy sequence (PRSS), and the
proton signals are converted into frequency information on the
spectrum. According to the American College of Radiology
BI-RADS-MRI lexicon, suspicious malignant lesions were
diagnosed on the basis of the morphological features of the
mass such as spiculated borders, microlobulated margins,
irregular masses and breast stroma architectural distortion.
Benign breast lesions were diagnosed based on their morpho-
logical feature (smooth masses of well deﬁned borders and
absence of surrounding breast stroma architectural distortion).
Time–signal intensity plots of dynamic images were generated
using console software. A small region of interest
(ROI > 3 pixels) was placed selectively over the most intensely
enhancing area of the lesion. The evaluation of enhancement
kinetic curve was based on initial phase (within the ﬁrst
2 min or when the curve starts to change), and late phase (after
2 min or after the change). The initial enhancement phase was
categorized into fast, medium, and slow. The late enhancement
phase was described as persistent, plateau, and washout. A
spectrum was considered ‘‘positive’’ for choline if there was a
well-deﬁned peak at 3.2 ppm. The MRS result was considered
‘‘negative’’ if there was no peak at 3.2 ppm with appearance of
adequate lipid suppression and shimming.
2.2. Histopathological study
The deﬁnitive diagnosis was provided by histopathological
examination of the biopsied tissue using ﬁne needle, core or
surgical biopsies or surgical excision. All radiologicalexamination results were compared with histopathological
results, and the latter was regarded as the standard reference.
2.3. Statistical analysis
The collected data were organized, tabulated and statistically
analyzed, using statistical package for social science (SPSS)
version 19 (SPSS Inc, Chicago, USA), running on IBM com-
patible computer with Microsoft Windows 7 operating
System. Mean, standard deviation, frequency and percentage
were used as descriptive; Chi square test (v2) was used for test-
ing signiﬁcance of observed differences between studied
patients. The level of signiﬁcance was adopted at p< 0.05%.
Sensitivity, speciﬁcity, positive predictive value, negative
Table 6 Distribution of benign and malignant solid breast lesions for each ultrasound BI-RADS class compared with
histopathological results.
Diagnosis Ultrasound BI-RADS classes
1 2 3 4 5 US results Histopathology results
Benign, n (%) 0 0 16 (80) 2 (40) 1 (6.7) 16 19
Malignant, n (%) 0 0 4 (20) 3 (60) 14 (93.3) 17 21
Total 0 0 20 5 15 40
Table 7 Distribution of benign and malignant solid breast lesions for each elastography color scoring compared with
histopathological results.
Diagnosis Elastography score
1 2 3 4 5 Elastography score Histopathology results
Benign, n (%) 0 4 (80) 13 (86.7) 1 (25) 1 (6.3) 17 19
Malignant, n (%) 0 1 (20) 2 (13.3) 3 (75) 15 (93.7) 18 21
Total 0 5 15 4 16 40
Table 8 Distribution of benign and malignant solid breast lesions for each DCE-MRI BI-RADS class compared with
histopathological results.
Diagnosis DCE-MRI BI-RADS classes
1 2 3 4 5 DCE-MRI results Histopathology results
Benign, n (%) 0 2 (66.7) 14 (93.3) 2 (40) 1 (5.9) 16 19
Malignant, n (%) 0 1 (33.3) 1 (6.7) 3 (60) 16 (94.1) 19 21
Total 0 3 15 5 17 40
Table 9 Choline results compared with histopathological
results.
Diagnosis Choline results
Negative Positive Total
choline
results
Total
histopathological
results
Benign, n (%) 17 (89.5) 2 (9.5) 17 19
Malignant, n (%) 2 (10.5) 19 (90.5) 19 21
Total 19 21 40
1304 M.M. Shakweer et al.predictive value and accuracy were used as measurements of
validity for MRI regarding histopathological results.
3. Results
Forty female patients were included in this study, their ages
ranged from 17 to 73 years (mean age 43.18 y), three patients
were lactating and 37 patients were non-lactating. Twenty-
eight cases presented clinically by painless breast lump
(70%), six cases with painful breast lump (15%), four cases
with nipple discharge (10%) and two cases with palpable
axillary lymph nodes (5%).In this study, there were 30 cases with no history of hor-
monal intake but 10 cases received oral HRT. Among them,
8 patients postmenopausal received oral HRT in the form of
estradiol and 2 cases received oral contraceptive pills.
Twenty-eight cases presented clinically by painless breast
lump (70%), six cases with painful breast lump (15%), four
cases with nipple discharge (10%) and two cases with palpable
axillary lymph nodes (5%).
On the basis of sonographic BI-RADS categorization, our
cases were classiﬁed as follows: (20 cases) class 3, (5 cases) class
4 and (15 cases) class 5. No case was assigned to class 0, 1, 2 or
6 (Table 6).
All benign lesions diagnosed by ultrasound were 16, while
the malignant lesions were 17. Fourteen malignant lesions
(14/21, 93.3%) were diagnosed BI-RADS 5, and sixteen benign
lesions (16/19, 80%) were diagnosed BI-RADS 3.
On the basis of elastographic color scoring categorization,
our cases were classiﬁed as follows: 5 cases (score 2), 15 cases
(score 3), 4 cases (score 4) and 16 cases (score 5) (Table 7) (see
Tables 8–10).
All benign lesions diagnosed by elastography were 17, while
the malignant lesions were 18. Fifteen malignant lesions
(15/21, 93.7%) had an elastography score 5. Thirteen benign
lesions (13/19, 86.7%) had an elastography score 3 (see
Figs. 1–3).
On the basis of MRI BI-RADS categorization, our cases
were classiﬁed as follows: (3 cases) class 2, (15 cases) class 3,
Table 10 Conventional ultrasound, ultrasound elastography, DCE-MRI and MRS sensitivity, speciﬁcity, PPV, NPV and accuracy in
diagnosis of solid breast lesions.
Examination Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
Conventional ultrasound 85 80 80.9 84.2 82.5
Ultrasound elastography 90 85 85.7 89.4 87.5
Dynamic contrast enhanced MRI (DCE-MRI) 85.7 84.2 85.7 84.2 85
MRI spectroscopy 90.4 89.4 90.4 89.5 80.8
Fig. 1 Chart represents the included patients according to
complaints/clinical signs.
Role of sonoelastography and MR spectroscopy 1305(5 cases) class 4 and (17 cases) class 5. No case was assigned to
class 0, 1 or 6 (Fig. 4) (see Figs. 5–7).
All benign lesions diagnosed by DCE-MRI were 16, while
the malignant lesions were 19. Sixteen malignant lesions
(94.1%) were diagnosed BI-RADS 5, while fourteen benign
lesions (93.3%) were diagnosed BI-RADS 3.
All benign lesions diagnosed by MRI spectroscopy were 17,
while the malignant lesions were 19. Nineteen malignant
lesions (90.5) had positive choline peak, while seventeen
(89.5%) benign lesions had negative choline peak.Fig. 2 Chart showing ultrasound BI-RADIn this study the conventional ultrasound sensitivity, speci-
ﬁcity, PPV, NPV and accuracy were 85%, 80%, 80.9%, 84.2%
and 82.5% respectively. Ultrasound elastography sensitivity,
speciﬁcity, PPV, NPV and accuracy were 90%, 85%, 85.7%,
89.4% and 87.5% respectively. Dynamic contrast enhanced
MRI sensitivity, speciﬁcity, PPV, NPV and accuracy were
85.7%, 84.2%, 85.7%, 84.2% and 85% respectively. MRS sen-
sitivity, speciﬁcity, PPV, NPV and accuracy were 90.4%,
89.4%, 90.4%, 89.5% and 80.5% respectively.
4. Discussion
Regarding the patients demography, there were 40 patients
included in our study. The mean age of the patients was
43.18 years (range of age, 17–73 years).
Many studies showed that the age at diagnosis of breast
cancer in Arab countries is a decade younger than that in
Western countries. In the United States, the median age at pre-
sentation for breast cancer is 61 years, compared to 50–
54 years in Egypt (7). Boivin et al. (8) stated that sonography
remains efﬁcient in the diagnosis of masses. In addition to their
diagnosis and characterization, it allows indispensable guided
biopsies or monitoring of their evolution during neoadjuvant
chemotherapy. The sonographic semiology of the masses does
not seem to change during lactation. The MRI has its own
semiology during lactation, related to the physiological
changes. Even so, it remains efﬁcient, allowing satisfactory
detection according to the BI-RADS classiﬁcation of tumors
by the American College of Radiology (ACR). Also Iman
et al. (9) mentioned that MRI breast should be used forS correlated to histopathological results.
Fig. 3 Chart showing elastography score correlated to histopathological results.
1306 M.M. Shakweer et al.undetermined cases and for staging of malignancy. Among the
patients in this study, 3 cases (7.5%) were lactating.
Age at menopause has long been identiﬁed as a risk factor
for breast cancer (10). Early menarche and late menopause are
known to increase women’s risk of developing breast cancer
(11). The menopausal state is an important differentiating fac-
tor in the classiﬁcation of patients with breast cancer. Instead
of classifying by age, women with breast cancer are separated
into either pre- or postmenopause (12). Among the patients of
this study, 21 cases (52.5%) were postmenopausal.
In our study, ten patients received hormonal therapy (HT).
Several studies have shown that the prognosis of HRT associ-
ated breast cancers is more favorable than that without HRT.
This may be due to their greater hormone dependency, earlier
diagnosis, lower tumor grades, better cooperation and surveil-
lance of the patients or other yet unidentiﬁed factors.
Although the studies showed an increased risk of breast cancer
among women taking HRT, the same patients survived longer
than women with breast cancer who did not take HRT (13).
The risk of breast cancer depends on duration of hormonal
therapy (HT) use, and is reduced after cessation of use, leveling
off after 5 years since quitting HT (14). The most presenting
complaint was painless breast lump which represented 28 cases
(70%) as breast mass was the most commonly reported ﬁrst
symptom. Furthermore, the development or increase in breastFig. 4 Dynamic MRI breast BI-RADS correlated with
histopathological results.mass size was the main cause for seeking medical care in three-
quarters of the patients (15).
Introduction of BI-RADS has provided a standardized
ultrasound categorization system for lesion morphology. It
has been successfully established in the interpretation of ultra-
sonography. Because the sonographic features of benign and
malignant lesions have been shown to over-ride largely with
each other, there are many false-negative and false-positive
ﬁndings. These limitations of BI-RADS, and great desire not
to miss a malignant lesion in the early stage of disease lead
to an aggressive biopsy. The biopsy rate for cancer is only
10–30%. This means that 70–90% of breast biopsies are per-
formed with benign diseases, which induce unnecessary patient
discomfort and anxiety besides increasing ﬁnancial cost of the
patient. Clearly, there is a great need for the development of
additional reliable methods to complement the existing diag-
nostic procedures to avoid unnecessary biopsy. Elastography
is a new modality in addition to US to detect and identify
the breast lesions. It can show another characteristic stiffness
of the lesion to the investigator and give some help in diagnosis
of breast lesions by US (16).
On the basis of sonographic BI-RADS categorization, our
cases were classiﬁed as follows: (20 cases) class 3, (5 cases) class
4 and (15 cases) class 5. The conventional ultrasound sensitiv-
ity in diagnosis of solid breast lesions was 85% and it was
lower than results of the literature by Leong et al. (17) in which
the sensitivity was 88.5%, while the speciﬁcity and accuracy
were 80% and 82.5% respectively and they were higher than
the results of the literature by Leong et al. (17) in which speci-
ﬁcity and accuracy were 42.5% and 53.6% respectively. The
histopathological results revealed 19 benign lesions and 21
malignant lesions.
On the basis of elastography score categorization, our cases
were classiﬁed as follows: (5 cases) score 2, (15 cases) score 3,
(4 cases) score 4 and (15 cases) score 5. In this study, the ultra-
sound elastography sensitivity, speciﬁcity, PPV, NPV and
accuracy were 90%, 85%, 85.7%, 89.4% and 87.5% respec-
tively. Sonoelastography was useful for differentiating between
benign and malignant lesions by evaluation of tissue elasticity
and hardness.
Generally, the elasticity of pathological tissue changes and
most of malignant tumors are constituted with hard lesion,
(A) Convenonal ultrasound (B) Ultrasound elastography (C) T1 WI without contrast 
(D) T2 WI (E) T2 SPAIR (F) Dynamic THRIVE (contrast)
(G) Dynamic THRIVE (Subtracon) (H) Time Intensity Curve (I) MRI spectroscopy
Fig. 5 62 years-old female with right breast lumps. US showed multiple speculated lesions with heterogeneous hypoechogenicity (A).
Elastography showed the lesions and the surrounding area blue with elastography score 5 (B). MRI showed multicentric ill-deﬁned
speculated lesions, low signal in T1 and T2 WIs (C), (D) and (E). Asymmetrical enlargement of right pectoralis muscle with abnormal
intrasubstance signal (C) and (D). Dynamic study showed heterogenous enhancement of all lesions with type III intensity curve pattern
(rapid washout) (F), (G) and (H). Single voxel MRS revealed positive choline peak (I). MRI diagnosis: multicentric malignant lesions (BI-
RADS V). Histopathological result: Multicentric Intraductal Carcinoma (IDC).
Role of sonoelastography and MR spectroscopy 1307adhered to adjacent structure, which decreases activity and
elasticity and therefore increases hardness (18). Based on the
results of this study, we can estimate the diagnostic value of
elastography because a good correlation was found between
the elastography scores and the histology results. In our study,
the PPV of elastography was 85.7%, lower than results from
the literature by Houelleu et al. (19) who showed PPV
91.9%, and higher than results from the literature by Saharand Omar (20) who showed PPV 70.6%. The NPV of elastog-
raphy was 89.4%, higher than results found in a study by
Houelleu et al. (19) in which the NPV was 61.3%.
The sensitivity of elastography in diagnosis of solid breast
lesions was 90%, lower than results from the literature by
Leong et al. (17) in which sensitivity was 100%, and slightly
lower than results from the literature by Sahar and Omar
(20) in which the sensitivity was 92.3%. The sensitivity of
(A) Convenonal ultrasound (B) Ultrasound elastography (C) T1 WI without contrast
(D) T2 WI (E) T2 SPAIR (F) Dynamic THRIVE (contrast)
(G) Dynamic THRIVE (Subtracon) (H) Time Intensity Curve (I) MRI spectroscopy
Fig. 6 38 years-old female with right breast well deﬁned oval shaped lesion. US showed homogeneous hypoechoic echo pattern with no
calciﬁcation or cystic degeneration (A). Elastography showed the lesion has mosaic pattern of green, blue and red, giving an elastography
score 2 (B). MRI showed low signals in T1 and intermediate signals in T2 WIs (C) and (D). Dynamic study showed homogeneous
enhancement of the lesion with type I intensity curve pattern (persistent curve) (F), (G) and (H). Single voxel MRS showed no evidence of
choline peak detected at the spectrum (I). MRI diagnosis: benign lesion (BI-RADS III). Histopathological result: Myxoid Fibroadenoma.
1308 M.M. Shakweer et al.elastography was also higher than results from the literature by
Houelleu et al. (19), Yerli et al. (21) and Qiao et al. (18) in
which sensitivity were 73.9%, 80% and 84.2% respectively.
The speciﬁcity of elastography was 85% and looks lower
than results from the literature by Yerli et al. (21) in which
speciﬁcity was 95%, and slightly lower than results from the
literature by Houelleu et al. (19) in which the speciﬁcity was
86.4%. The speciﬁcity of elastography was also higher thanresults from the literature by Sahar and Omar (20), Leong
et al. (17) and Qiao et al. (18) in which speciﬁcity was
74.1%, 73.8% and 84.6% respectively. The accuracy of elas-
tography was 87.5%, higher than results from the literature
by Leong et al. (17) in which accuracy was 80%.
Dynamic contrast enhanced (DCE) magnetic resonance
imaging (MRI) is an established technique for detection,
diagnosis and staging of breast cancer. However, it has an
(A) Convenonal ultrasound (B) Ultrasound elastography (C) T1 WI without contrast
(D) T2 WI (E) T2 SPAIR (F) Dynamic THRIVE (contrast)
(G) Dynamic THRIVE 
(Subtracon) 
(H) Time Intensity Curve (I) MRI spectroscopy
Fig. 7 32 years-old female with right breast lesion. US showed heterogeneous hypoechoic pattern (A). Elastography showed the lesion in
blue with score 4 (B). MRI showed ill-deﬁned speculated lesion, low signals in T1 and intermediate signals in T2 WIs (C), (D) and (E). The
lesion showed invasion of suspensory ligament with subsequent nipple retraction and subjacent focal skin thickening. Focal bulge in the
pectoralis major muscle suspected inﬁltration. Dynamic study showed heterogenous enhancement of the lesion with type III intensity
curve pattern (F), (G) and (H). Single voxel MRS revealed positive choline peak (I). MRI diagnosis: malignant lesion with pectoralis
muscle inﬁltration (BI-RADS V). Histopathological result: intraductal carcinoma (IDC) with muscle invasion.
Role of sonoelastography and MR spectroscopy 1309inherently high sensitivity but only moderate speciﬁcity for
characterization of breast lesions. The standard breast imaging
protocol enables the analysis of the morphological and kinetic
patterns of benign and malignant breast lesions detected at
MRI (Tan et al. (22)).On the basis of MRI BI-RADS categorization, our cases
were classiﬁed as follows: (3 cases) class 2, (15 cases) class 3,
(5 cases) class 4 and (17 cases) class 5, and showed DCE-
MRI sensitivity, accuracy, PPV and NPV of 85.7%, 85%,
85.7% and 84.2% respectively, which is lower than results of
1310 M.M. Shakweer et al.the literature by Pinker et al. (23) in which the sensitivity, accu-
racy, PPV and NPV were 97.6%, 89.8%, 89.1% and 92.3%
respectively. The speciﬁcity was 84.2% and it was higher than
results of the literature by Pinker et al. (23) in which speciﬁcity
was 70.6%. Regarding MRI spectroscopy, there were 19
malignant lesions with positive choline peak in contrast with
17 benign lesions with negative choline peak.
Suppiah et al. (24) stated that, in a study conducted using
1.5 T MR systems reported the presence of the resonance of
total choline (tCho) containing compounds at 3.2 parts per
million (ppm), which includes contributions from choline,
phosphocholine, glycerophosphocholine and taurine as reli-
able biomarkers of breast cancer. This is because choline-
containing metabolites detected in breast lesions are an indica-
tor of the increased cellular metabolism noted in malignant
breast tumors. In our study the sensitivity of MRI spec-
troscopy was 90.4%, which is lower than results from the liter-
ature by Suppiah et al. (24) and Naglaa et al. (25) in which
sensitivity was 95.2% and 96.7% respectively. The sensitivity
of MRI spectroscopy was also higher than results from the lit-
erature by Katerina et al. (26) and Pascal et al. (27) in which
sensitivity was 80% and 62% respectively.
In this study the speciﬁcity of MRI spectroscopy was
89.4%, which is lower than results from the literature by
Suppiah et al. (24) and Naglaa et al. (25) in which speciﬁcity
was 93.3% and 95.5% respectively. The speciﬁcity of MRI
spectroscopy was also higher than results from the literature
by Katerina et al (26) and Pascal et al. (27) in which speciﬁcity
was 81.8% and 86% respectively. The PPV of MRI spec-
troscopy was 90.4%, so it is lower than results from the liter-
ature by Suppiah et al. (24) in which PPV was 97.6%, and
slightly higher than results from the literature by Pascal
et al. (27) in which the PPV was 90%. The NPV of MRI spec-
troscopy was 89.5.4% and looks higher than results from the
literature by Suppiah et al. (24) in which PPV was 87.2%.
The accuracy of MRI spectroscopy was 80.8% and looks
slightly higher than results from the literature by Katerina
et al. (26) in which accuracy was 80.7%.
Regarding our study, there were a few limitations of elas-
tography as follows:
First, this was a relatively small study where the number of
malignant cases was small. A larger pool of malignancies is
required to assess ‘‘soft’’ tumours, such as mucinous carcino-
mas, cancers that do not incite signiﬁcant desmoplastic reac-
tion (e.g. invasive lobular carcinoma), and tumors with
central necrosis or solid-cystic complex appearance, all of
which can elicit a benign appearance on elastographic scoring
system because of their soft interiors.
Second, ultrasound elastography, as with most ultrasound
applications, is user-dependent. The amount of pressure to be
applied on the breast when performing elastography, the recog-
nition of the various elastographic patterns and the measure-
ment techniques were some of the areas that were subjective
and these limitations were also mentioned by Leong et al. (17).
As regards MRS limitations, some lesions that had erratic
spectra due to technical problems (i.e. patient breathing/move-
ment artefacts, susceptibility artefacts due to ﬁeld inhomo-
geneity, and inability to perform proper high-order
shimming for certain lesions) were also excluded. It would
have also been better to perform MRS for normal tissue on
the non-lesion containing breast, as the peritumoralenvironment could inﬂuence the tCho measurements and this
was in accordance with Suppiah et al. (24).Conﬂict of interest
No conﬂict of interest.
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